Delivery Order SPE2DB24D1107-SPE2DB24FZEU5
Award Date
6/27/24
Potential Completion Date
6/28/24
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count bottles to the Defense Logistics Agency (DLA). The $1,218.75 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024, with an ultimate completion date of June 26, 2024. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Amerisourcebergen and the DLA, which serves as the primary...
This federal contract award is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $1,443.67 and a completion date of November 4, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
This federal contract award is for the delivery of Losartan-HCTZ 100-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distribution company. The contract has a ceiling value of $13,318.06 and a completion date of June 26, 2024. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages to the Defense Logistics Agency (DLA). The $2,043.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 29, 2024, with a completion date of July 30, 2024. The contract has no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Losartan-HCTZ 100-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for a fixed price of $19,370.98. The contract has an ultimate completion date of August 27, 2024 and is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The IDC is with the DLA Troop...
This federal contract award is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The $6,121.50 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Losartan-HCTZ 100-25 mg tablets in 1,000 count bottles. The $5,172.63 firm fixed-price delivery order is not associated with a set-aside program. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This single-award IDC serves as the...
This federal contract award is for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $7,235.36 and an ultimate completion date of February 28, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count bottles, with a ceiling value of $5,380.45 and a completion date of June 27, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 per bottle. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $8,042.04 and was awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued up to $999,999,999.00 and...